跳至主要内容
临床试验/NCT07673783
NCT07673783尚未招募不适用

Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients: Insights Into Fluid Biomarkers of Neuroinflammation and Correlations With Clinical Outcomes

Fondazione Policlinico Universitario Agostino Gemelli IRCCS0 个研究点目标入组 90 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
主要终点
To characterize neuroinflammatory effects of deep brain stimulations

研究概览

简要总结

The aim of the study is to characterize the neuroinflammatory effects of subthalamic deep brain stimulation in patients with Parkinson's disease, by analyzing changes in blood neuroinflammatory and neurodegenerative biomarkers before and after surgery (at 6 and 12 months, respectively), and comparing the changes in blood biomarkers levels with a control group of patients with advanced PD on best medical treatment.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinically established diagnosis of PD according to the criteria of the Movement Disorder Society (MDS) (Postuma et al., Mov Disord 2015);
  • a minimum disease duration of 4 years;
  • eligibility for STN-DBS surgery according to Core Assessment Program for Surgical Interventional Therapies in PD (Defer et al., Mov Disord 1999);
  • age between 18 and 75 years.

排除标准

  • inability to express an informed consent;
  • moderate or severe cognitive impairment (score < 24 on the Mini-Mental State Examination);
  • severe psychiatric symptoms (e.g., psychosis, major depression);
  • previous neurosurgical interventions for PD;
  • pregnancy;
  • ongoing inflammatory or autoimmune diseases;
  • chronic infectious diseases;
  • active neoplasms;
  • chronic intake of anti-inflammatory drugs (e.g. steroids or NSAIDs).

研究组 & 干预措施

DBS group

Patients with advanced Parkinson's disease who will undergo deep brain stimulation surgery, according to clinical practice, will be assigned to this group.

干预措施: Deep brain stimulation surgery (Device)

Control group

Patients with advanced Parkinson's disease on best medical treatment, potentially eligible for DBS but who refuse this therapy, will be allocated in this group

结局指标

主要结局

To characterize neuroinflammatory effects of deep brain stimulations

时间窗: 12 months

The main aim of the study is to characterize the neuroinflammatory effects of STN-DBS in PD patients, by analyzing changes in blood neuroinflammatory and neurodegenerative biomarkers before and after surgery (at 6 and 12 months, respectively), and comparing the changes in blood biomarkers levels with a control group of patients with advanced PD on best medical treatment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验